Novartis unit Sandoz starts trading at 24 Swiss francs after completing spinoff – CNBC
Business News
- Novartis unit Sandoz starts trading at 24 Swiss francs after completing spinoff CNBC
- Novartis to Complete Spinoff of Generic Drug Division Barron’s
- Novartis positioning is now best-suited for long-term gains and returns after spin-off, says CEO CNBC Television
- Novartis’ Sandoz valued at $11.2 bln in market debut Reuters
- Sandoz Starts Trading in Final Step After Novartis Split Bloomberg
- View Full Coverage on Google News
Source: Business News